Edgewood Management LLC Royalty Pharma PLC Transaction History

Edgewood Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$36.14 - $42.24 $722,800 - $844,800	-20,000 Reduced 46.51%	23,000 $831,000
Q2 2021 Aug 12, 2021	SELL	$39.85 - $46.63 $2.13 Million - $2.49 Million	-53,500 Reduced 55.44%	43,000 $1.76 Million
Q4 2020 Feb 12, 2021	BUY	$36.12 - $50.05 $234,779 - $325,325	6,500 Added 7.22%	96,500 $4.83 Million
Q3 2020 Nov 12, 2020	BUY	$38.56 - $48.36 $771,200 - $967,200	20,000 Added 28.57%	90,000 $3.79 Million
Q2 2020 Aug 12, 2020	BUY	$44.5 - $52.11 $3.12 Million - $3.65 Million	70,000 New	70,000 $3.4 Million

413

283M

578K

47.5K

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $10.6B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

Get notified when there are updates to the investment portfolio of Edgewood Management LLC, based on Form 13F filings with the SEC.

Stay updated on Edgewood Management LLC with notifications on news.